Clinical Report: The Right Choices in Biomanufacturing

Background

Biomanufacturing is a critical component of the biopharmaceutical industry. The choice of manufacturing technology can significantly impact productivity, cost, and supply chain security.

Data Highlights

No numerical data provided in the source material.

Key Findings

• Manufacturing is increasingly viewed as a strategic imperative in biopharma.
• Continuous bioprocessing is supported by global guidance such as ICH Q13 and FDA strategies.
• Single-use systems (SUS) are subject to specific regulatory expectations for contamination control.
• Scaling up biomanufacturing processes is critical for long-term product lifecycle management.
• Industry standards like ASME BPE provide guidelines for hygienic design in both stainless steel and SUS configurations.

Clinical Implications

Healthcare professionals involved in biomanufacturing should stay informed about regulatory updates and best practices for manufacturing technologies.

Conclusion

Continuous evaluation of manufacturing strategies is essential for maintaining competitiveness.

Related Resources & Content

1. The Connected Process, The Medicine Maker, 2018 -- The Connected Process
2. Don't Get a Raw Deal, The Medicine Maker, 2022 -- Don't Get a Raw Deal
3. The Importance of a Manufacturing Strategy: Lessons Learned with Steve Lam, The Medicine Maker, 2017 -- The Importance of a Manufacturing Strategy
4. Q13 Continuous Manufacturing of Drug Substances and Drug Products | FDA, FDA -- Q13 Continuous Manufacturing
5. Guidance on good manufacturing practice and good distribution practice: Questions and answers | European Medicines Agency (EMA), EMA -- GMP/GDP Q&A
6. the medicine maker — What Makes a “Good” Bioprocess?
7. Q13 Continuous Manufacturing of Drug Substances and Drug Products | FDA
8. Guidance on good manufacturing practice and good distribution practice: Questions and answers | European Medicines Agency (EMA)
9. Plastic Components and Systems Used to Manufacture Pharmaceutical Drug Products and Biopharmaceutical Drug Substances and Products | USP-NF